106 related articles for article (PubMed ID: 1388567)
1. Comparison of cell proliferation in breast carcinoma using image analysis (Ki-67) and flow cytometric systems.
Kennedy JC; el-Badawy N; DeRose PB; Cohen C
Anal Quant Cytol Histol; 1992 Aug; 14(4):304-11. PubMed ID: 1388567
[TBL] [Abstract][Full Text] [Related]
2. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.
Dawson AE; Norton JA; Weinberg DS
Am J Pathol; 1990 May; 136(5):1115-24. PubMed ID: 1972000
[TBL] [Abstract][Full Text] [Related]
4. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
Lee AK; Wiley B; Loda M; Bosari S; Dugan JM; Hamilton W; Heatley GJ; Cook L; Silverman ML
Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
7. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.
Lee AK; Wiley B; Dugan JM; Hamilton WH; Loda M; Heatley GJ; Cook L; Silverman ML
Pathol Res Pract; 1992 Jun; 188(4-5):428-32. PubMed ID: 1329051
[TBL] [Abstract][Full Text] [Related]
8. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.
Swanson SA; Brooks JJ
Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714
[TBL] [Abstract][Full Text] [Related]
9. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
MacGrogan G; Jollet I; Huet S; Sierankowski G; Picot V; Bonichon F; Coindre JM
Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.
Weidner N; Moore DH; Vartanian R
Hum Pathol; 1994 Apr; 25(4):337-42. PubMed ID: 8163266
[TBL] [Abstract][Full Text] [Related]
11. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
[TBL] [Abstract][Full Text] [Related]
12. Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations.
Sahin AA; Ro JY; el-Naggar AK; Wilson PL; Teague K; Blick M; Ayala AG
Am J Clin Pathol; 1991 Oct; 96(4):512-9. PubMed ID: 1716414
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count.
Isola JJ; Helin HJ; Helle MJ; Kallioniemi OP
Cancer; 1990 Mar; 65(5):1180-4. PubMed ID: 2406010
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of different methods for determination of proliferative activity of breast carcinomas].
Mink D; Villena-Heinsen C; Tossounidis I; Schmidt W
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():53-6. PubMed ID: 8672927
[TBL] [Abstract][Full Text] [Related]
18. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
[TBL] [Abstract][Full Text] [Related]
19. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
20. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]